SEC Info℠ | Home | Search | My Interests | Help | Sign In | Please Sign In | ||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 6/30/23 Onconova Therapeutics, Inc. S-3 4:440K Toppan Merrill/FA |
Document/Exhibit Description Pages Size 1: S-3 Registration Statement - Securities for a HTML 290K Transaction 2: EX-5.1 Opinion of Counsel re: Legality HTML 29K 3: EX-23.1 Consent of Expert or Counsel HTML 5K 4: EX-FILING FEES Filing Fees HTML 54K
tm2320218-1_s3 - none - 3.1875284s |
|
Delaware
(State or other jurisdiction of
incorporation or organization) |
| |
22-3627252
(I.R.S. Employer
Identification No.) |
|
|
Large accelerated filer
☐
|
| | | | |
Accelerated filer
☐
|
|
|
Non-accelerated filer
☐
|
| | | | |
Smaller reporting company
☒
|
|
| | | | | | |
Emerging growth company
☐
|
|
| | |
Page
|
| |||
| | | | 1 | | | |
| | | | 1 | | | |
| | | | 2 | | | |
| | | | 3 | | | |
| | | | 5 | | | |
| | | | 5 | | | |
| | | | 5 | | | |
| | | | 6 | | | |
| | | | 7 | | | |
| | | | 7 | | | |
| | | | 9 | | | |
| | | | 12 | | | |
| | | | 12 | | | |
| | | | 13 | | | |
| | | | 14 | | | |
| | | | 14 | | |
|
Securities and Exchange Commission registration fee
|
| | | $ | 11,665.68(1) | | |
|
FINRA fee (if applicable)
|
| | | | * | | |
|
Printing expenses
|
| | | | * | | |
|
Legal fees and expenses
|
| | | | * | | |
|
Accounting fees and expenses
|
| | | | * | | |
|
Transfer agent and trustee fees and expenses
|
| | | | * | | |
|
Miscellaneous
|
| | | | * | | |
|
Total
|
| | | $ | * | | |
Exhibit No.
|
| |
Description of Exhibit
|
|
4.26* | | | Form of Warrant | |
4.27* | | | Form of Warrant Agreement for Common Stock, including Warrant Certificate for Common Stock | |
4.28* | | | Form of Warrant Agreement for Preferred Stock, including Warrant Certificate for Preferred Stock | |
4.29* | | | Form of Warrant Agreement for Debt Securities, including Warrant Certificate for Debt Securities | |
4.30* | | | Form of Unit Agreement | |
5.1*** | | | | |
23.1*** | | | | |
23.3*** | | | Consent of Morgan, Lewis & Bockius LLP (included in the opinion filed as Exhibit 5.1) | |
24.1*** | | | Power of attorney (included on the signature page of this registration statement) | |
25.1** | | | Form T-1 Statement of Eligibility and Qualification under the Trust Indenture Act of 1939 of Trustee for Form of Indenture. | |
107 | | | |
|
Name
|
| |
Title
|
| |
Date
|
|
|
|
| | Director, President and Chief Executive Officer (Principal Executive Officer) | | | | |
|
/s/ Mark Guerin
|
| | Chief Operating Officer and Chief Financial Officer (Principal Financial Officer and Principal Accounting Officer) | | | | |
|
/s/ James J. Marino
|
| | Chairman, Board of Directors | | | | |
|
|
| | Director | | | | |
|
|
| | Director | | | | |
|
|
| | Director | | | | |
|
|
| | Director | | | |
This ‘S-3’ Filing | Date | Other Filings | ||
---|---|---|---|---|
Filed on: | 6/30/23 | |||
6/29/23 | ||||
3/31/23 | 10-Q | |||
3/30/23 | 10-K | |||
12/31/22 | 10-K, 10-K/A, ARS | |||
3/31/22 | 10-Q | |||
4/24/20 | S-3 | |||
List all Filings |
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 7/07/23 SEC UPLOAD¶ 8/08/23 2:39K Onconova Therapeutics, Inc. |